PRLD · Company research
Prelude Therapeutics Incorporated (PRLD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Down 27.4% in 4 Weeks, Here's Why Prelude Therapeutics (PRLD) Looks Ripe for a Turnaround - Yahoo Finance UK | Down 27.4% in 4 Weeks, Here's Why Prelude Therapeutics (PRLD) Looks Ripe for a Turnaround Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 16, 2026 | neutral | 0 | 0.6 |
| Lilly will supply two drugs for Prelude's planned breast cancer trial. - Stock Titan | Lilly will supply two drugs for Prelude's planned breast cancer trial. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Why (PRLD) Price Action Is Critical for Tactical Trading - Stock Traders Daily | Why (PRLD) Price Action Is Critical for Tactical Trading Stock Traders Daily | View source ↗ | Stock Traders Daily | Aug 28, 2026 | neutral | 0 | 0.6 |
| Prelude Therapeutics: A Prognosis After Year Long Rally (NASDAQ:PRLD) - Seeking Alpha | Prelude Therapeutics: A Prognosis After Year Long Rally (NASDAQ:PRLD) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 23, 2026 | neutral | 0 | 0.6 |
| Prelude Therapeutics (PRLD) Stock Rallies As Losses Ease But Milestones Remain Unclear - Simply Wall Street | Prelude Therapeutics (PRLD) Stock Rallies As Losses Ease But Milestones Remain Unclear Simply Wall Street | View source ↗ | Simply Wall Street | Aug 11, 2026 | neutral | 0 | 0.6 |
| Prelude Therapeutics reports Q2 2026 results: $5.7M revenue, $13.9M net loss, $155.2M cash - TradingView | Prelude Therapeutics reports Q2 2026 results: $5.7M revenue, $13.9M net loss, $155.2M cash TradingView | View source ↗ | TradingView | Aug 11, 2026 | neutral | 0 | 0.6 |
| $PRLD stock is up 19% today. Here's what we see in our data. - Quiver Quantitative | $PRLD stock is up 19% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 28, 2026 | neutral | 0 | 0.6 |
| $PRLD stock is up 19% today. Here's what we see in our data. - Quiver Quantitative | $PRLD stock is up 19% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 28, 2026 | neutral | 0 | 0.6 |
| Prelude Therapeutics (PRLD) Upgraded to Buy: Here's Why - Yahoo Finance | Prelude Therapeutics (PRLD) Upgraded to Buy: Here's Why Yahoo Finance | View source ↗ | Yahoo Finance | Jul 17, 2026 | neutral | 0 | 0.6 |
| Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD) - Yahoo Finance | Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD) Yahoo Finance | View source ↗ | Yahoo Finance | May 31, 2026 | neutral | 0 | 0.6 |
| Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock - Investing.com | Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock Investing.com | View source ↗ | Investing.com | Apr 23, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $PRLD Buys 1,689,189 Shares - Quiver Quantitative | Insider Purchase: Director at $PRLD Buys 1,689,189 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 23, 2026 | neutral | 0 | 0.6 |
| Why Did PRLD Stock Surge 13% Today? - Stocktwits | Why Did PRLD Stock Surge 13% Today? Stocktwits | View source ↗ | Stocktwits | Feb 3, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 26, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.